University of California, Los Angeles will participate in research to test the efficacy of coronavirus vaccines on people who work in healthcare.
After getting the CDC’s $4.90 million grant, the DGSOM researchers will work jointly with the University of Iowa’s Carver medical school and research those healthcare employees for one year.
The Food and Drug Administration debated and looked at the information for all the coronavirus vaccines authorized in the nation. Every single corresponding company that specializes in developing pharmaceuticals conducted research that demonstrated the vaccine’s efficacy.
With the financing from the US CDC, each of the universities mentioned above may collect its findings with the help of more recent COVID-19 subjects.
Some of their research will examine the non-vaccinated and vaccinated healthcare employees with coronavirus disease-like symptoms. The said examination will be to know to what extent their symptoms become severe, as well as whether the workers would test COVID-19 positive.
The UCLA Emergency Medicine department’s David Talan will lead the study.
Healthcare workers worldwide have contributed to meeting the overwhelming requirements of patients, communities, and families in the epidemic period, said Talan in a recent press release. Talan also highlighted the priority-based vaccination treatment given to all those healthcare workers. There is an obligation for healthcare industry people to learn the maximum things regarding the vaccine’s efficacy and safety, said Talan.
The PREVENT project is all set to work with healthcare professionals in 16 different national medical centers. At the same time, volunteers will still be accepted as part of the project.
Over 3,800,000 vaccine doses have already been distributed in Los Angeles County, and many of those are second dosages.
California would expand the eligibility for the vaccination to those aged 50 years or above on April 01, 2021, before further opening eligibility to every 16-year-old native, without any restrictions.
